AGREEMENT
EXHIBIT A
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Theseus Pharmaceuticals, Inc.
Date: January 23, 2023 | XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | |||||
By: | FHMLSP, L.P., its General Partner | |||||
By: | FHMLSP, L.L.C., its General Partner | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | FHMLSP, L.P. | |||||
By: | FHMLSP, L.L.C., its General Partner | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | FHMLSP, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P. | |||||
By: | FHMLSP Overage, L.P., its General Partner | |||||
By: | FHMLSP Overage, L.L.C., its General Partner | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | FHMLSP OVERAGE, L.P. | |||||
By FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | FHMLSP OVERAGE, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | XXXXXXX LIFE SCIENCES XI, L.P. | |||||
By: | FHMLS XI, L.P., its General Partner | |||||
By: | FHMLS XI, L.L.C., its General Partner | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer |
Date: January 23, 2023 | FHMLS XI, L.P. | |||||
By: | FHMLS XI, L.L.C., its General Partner | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | FHMLS XI, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: January 23, 2023 | By: | * | ||||
Xxxxx X. Xxxxxx | ||||||
Date: January 23, 2023 | By: | * | ||||
Xxxxxxx X. Xxxxx | ||||||
Date: January 23, 2023 | By: | ** | ||||
Xxxxxx Xxx | ||||||
Date: January 23, 2023 | By: | ** | ||||
Xxxxx Xxxxx | ||||||
Date: January 23, 2023 | By: | *** | ||||
Xxxxxx Xxxxx | ||||||
Date: January 23, 2023 | By: | /s/ Xxxxx X. Xxxxxx | ||||
Xxxxx X. Xxxxxx, as Attorney-in-Fact |
* | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016. |
** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |
*** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022. |